Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

* Inclusion Criteria * Age between 20 to 45, healthy male subjects (at screening) * BMI between 18 - 27 kg/m2 (at screening) * Blood pressure SBP 90-140 mmHg, DBP 60-95 mmHg * FPG 70-125mg/dL glucose level (at screening) * Subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the * Exclusion Criteria * Subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, Neurology,immunology,pulmonary,endocrine,hematooncology,cardiology,mental disorder.) * Subject who had GI tract disease that influencable to drug absorption or(ulcer, acute or chronic pancreatitis) surgery.(appendectomy, hernioplasty are not included) * Subject who had drug hypersensitivity reaction.(gemigliptin, irbesartan, aspirin, antibiotics) * Subject who already admitted in other investigator product in 80 days * Subject who had whole blood donation in 60 days, or component blood donation in 30 days or transfusion in 30 days currently